More collaboration is needed to understand chemo brain fog

04/2/2013 | Scientist, The (free registration)

Researchers are studying the effects of cancer drugs on the brain in an effort to understand and prevent cognitive decline, or "chemo brain." Mouse studies have shown exercise and the antidepressant fluoxetine might slow or reverse cognitive decline, but the studies do not reflect real-world chemotherapy regimens, writes Ellen Walker, a professor of pharmaceutical sciences at Temple University who is researching chemo brain. The scientific community needs to develop more informative models and set standards for cognitive testing to identify at-risk patients and develop preventive therapies, Walker writes.

View Full Article in:

Scientist, The (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations